The present invention relates to compounds consisting of glycolipidscovalently bound to an antigen or a drug viaa linker. The said compounds are able to induce a stronger immune responsethan a composition comprising separated glycolipidsand antigen. The said compounds are also able to target drug to CD1drestricted cells.